Genus acquires Brazilian bovine IVF firm


Cow breeder Genus (LON:GNS) unveiled a deal to acquire a controlling stake in a Brazilian business focused on bovine in-vitro fertilisation (IVF).

Genus is paying £4.3mln in cash to acquire a 51% stake in Vitro Brasil, and it has the option to acquire the other 49% in the first half of 2018.

The company says Brazil is the world’s largest bovine IVF market, and Vitro Brasil has a leading position in the country.

It adds that the acquisition will help Genus accelerate ‘genetic improvement’ for its customers.

"The acquisition of IVB provides Genus with a significant opportunity to accelerate the rate of genetic improvement we are able to offer our customers,” said chief executive Karim Bitar.

“IVB's proven success in delivering IVF solutions to commercial dairy and beef producers will enable us to offer our extensive customer base the ability to leverage genetic improvement on both the male and female side of their herds through superior in-house technology."

Quick facts: Genus

Price: £25.32

Market: LSE
Market Cap: £1.65 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Zena Pay looks to help cannabis industry navigate the...

Fig House communication’s Dave Carter joined Steve Darling from Proactive Vancouver to discuss Zena Pay. They provide software solutions that specialize in payment, plant tracking, cannabis business management software, supply chain management, compliance management and government auditing...

1 day, 10 hours ago

2 min read